AbbVie: Endometriosis trials

The registry lists 20 Endometriosis studies with AbbVie as lead sponsor. 0 are open to participants now and 14 have results posted.

Phase 2 8Phase 3 7No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe PainTerminatedNCT03343067Phase 3Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCompletedNCT03213457Phase 3Results posted
• Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated PainCompletedNCT02143713Phase 3Results posted
• A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCompletedNCT01931670Phase 3Results posted
• Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated PainCompletedNCT01760954Phase 3Results posted
• Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic EndometriosisCompletedNCT01728454Phase 2Results posted
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCompletedNCT01620528Phase 3Results posted
• Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)CompletedNCT01294371Results posted
• Efficacy and Safety Study of Elagolix in Women With EndometriosisCompletedNCT00973973Phase 2Results posted
• Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension StudyTerminatedNCT00958412Phase 2Results posted
• Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in EndometriosisCompletedNCT00797225Phase 2Results posted
• An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With EndometriosisCompletedNCT00619866Phase 2Results posted
• Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic EndometriosisTerminatedNCT00556075Phase 2Results posted
• Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCompletedNCT00437658Phase 2Results posted
• Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated PainCompletedNCT04630990
• A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and CapsulesTerminatedNCT04464187
• Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe PainActive, not recruitingNCT04333576Phase 3
• A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirmed Endometriosis and the Impact on the Disease or Symptom Progression.TerminatedNCT04140175
• Real-World Experience Study of Elagolix For the Treatment of Endometriosis in CanadaCompletedNCT04080856
• Open-Label Extension Study to ZPE-202WithdrawnNCT01961908Phase 2